---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-22-002702"
form_type: "8-K"
ticker: "BICX"
cik: "0001443863"
company_name: "BioCorRx Inc."
filed_at: "2022-04-28T23:59:59+00:00"
generated_at: "2026-06-26T03:20:23.331876+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# BioCorRx adopts 2022 Omnibus Plan authorizing 695,000 shares for equity incentives

## Summary
- Board approved 2022 Omnibus Securities and Incentive Plan on April 22, 2022; replaces 2018 plan.
- Plan reserves 695,000 shares of common stock for future equity awards.
- Non-employee director annual compensation cap set at $300,000 (equity + cash).
- Outstanding 2018 plan awards continue; forfeited shares become available under 2022 plan.
- Plan permits options, restricted stock, units, performance units, SARs and distribution equivalent rights.

## SEC filing metadata
- accession: 0001477932-22-002702
- form_type: 8-K
- ticker: BICX
- cik: 0001443863
- company_name: BioCorRx Inc.
- filed_at: 2022-04-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1443863/000147793222002702/0001477932-22-002702-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1443863/000147793222002702/bicx_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-22-002702
- JSON: https://secwatch.observer/filing/0001477932-22-002702.json
- Plain text: https://secwatch.observer/filing/0001477932-22-002702.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.